Helping patients understand breast cancer risk and screening options
Core D: Patient Centered Outcomes and Risk Communication
This project creates clearer, personalized ways to explain breast cancer risk and screening so people can make informed choices.
Quick facts
| Grant type | P01 program project |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-11191525 on NIH RePORTER |
What this research studies
You would be given personalized information about your breast cancer risk and clear explanations of screening and prevention options. The team will try different ways of communicating risk and recommendations and gather your feedback on how understandable and acceptable they are. They will measure how communication affects feelings, willingness to follow recommendations, and real-world screening behavior, as well as the personal costs and emotional impact. All information collected will help shape guidance and tools to make personalized screening easier to use.
Who could benefit from this research
Good fit: Women eligible for routine breast cancer screening, especially those at higher-than-average risk or considering personalized screening or prevention options, are the main candidates.
Not a fit: People outside recommended screening ages, those already living with advanced breast cancer, or those not willing to engage with screening decisions may not directly benefit.
Why it matters
Potential benefit: If successful, this work could help people better understand their breast cancer risk, follow screening or prevention advice more consistently, and avoid unnecessary tests.
How similar studies have performed: Related decision-support and risk-communication programs have improved understanding and screening adherence for some groups, though fully personalized screening approaches remain under development.
Where this research is happening
San Francisco, United States
- University of California, San Francisco — San Francisco, United States (Active)
Researchers
- Principal investigator: Naeim, Arash — University of California, San Francisco
- Study coordinator: Naeim, Arash
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.